Cindy Perier (Cindy Périer)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

High Throughput

Spinal Cord Injury

Escherichia Coli

Top Venues

Science advances

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Cindy Perier, Vincent Martin, Sylvie Cornet, Christine Favre-Guilmard, Marie-Noelle Rocher, Julien Bindler, Stéphanie Wagner, Emile Andriambeloson, Brian Rudkin, Rudy Marty, Alban Vignaud, Matthew Beard, Stéphane Lezmi, Mikhail Kalinichev
Recombinant botulinum neurotoxin serotype A1 in vivo characterization. Pharmacology research & perspectives 9 (5) (2022)
David Burgin, Cindy Perier, Gavin Hackett, Mark Elliott, Daniel Kwan, Fraser Hornby, Imran Mir, Jacquie Maignel, Sai Man Liu, Matthew Beard
New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency. Toxins 13 (12) (2021)
Mark Elliott, Christine Favre-Guilmard, Sai Man Liu, Jacquie Maignel, Geoffrey Masuyer, Matthew Beard, Christopher Boone, Denis Carré, Mikhail Kalinichev, Stephane Lezmi, Imran Mir, Camille Nicoleau, Shilpa Palan, Cindy Perier, Elsa Raban, Sicai Zhang, Min Dong, Pål Stenmark, Johannes Krupp
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models. Science advances 5 (1) (2019)